1. Academic Validation
  2. Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus Cystobasidium laryngis and Their Biological Activities

Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus Cystobasidium laryngis and Their Biological Activities

  • J Nat Prod. 2022 Apr 22;85(4):857-865. doi: 10.1021/acs.jnatprod.1c00985.
Hwa-Sun Lee 1 Jong Soon Kang 2 Duk-Yeon Cho 3 Dong-Kug Choi 3 Hee Jae Shin 1 4
Affiliations

Affiliations

  • 1 Marine Natural Products Chemistry Laboratory, Korea Institute of Ocean Science Technology, 385 Haeyang-ro, Yeoungdo-gu, Busan 49111, Republic of Korea.
  • 2 Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeoungudanji-ro, Cheongju 28116, Republic of Korea.
  • 3 Department of Applied Life Science, Graduate School of Konkuk University, Chungju 27478, Republic of Korea.
  • 4 Department of Marine Biotechnology, University of Science and Technology (UST), 217 Gajung-ro, Yuseong-gu, Daejeon 34113, Republic of Korea.
Abstract

Phenazostatins E-J (1-6), six new diphenazine derivatives, were isolated from the EtOAc extract of the culture broth of a strain of Cystobasidium laryngis derived from deep-sea sediments of the Indian Ocean Ridge. The structures of 1-6 were elucidated based on the HRESIMS and 1D and 2D NMR spectra. The absolute configurations of 1-6, except for 3 and 6, were determined by modified Mosher's method, ECD data analysis, and calculations of optical rotation values. The absolute configurations of 3 and 6 were identified by chemical derivatization and comparing the specific rotation values with those of semisynthetic 3 obtained by the oxidation of 1 and saphenic acid (7). Phenazostatin J (6) was semisynthesized using saphenic acid (7) to prepare additional material for biological testing. During the purification of semisynthetic 6, a side product 9 was obtained from the reaction mixture along with 6. Compounds 1-6, along with previously reported 7 and 8, were assessed for anti-neuroinflammatory activity in LPS-induced BV-2 microglia cells. Compound 6 exhibited the highest anti-neuroinflammatory effect with an IC50 value of 0.30 μM, but it showed cytotoxicity at higher concentrations than 1.0 μM. Accordingly, cytotoxicities of 1-9 were evaluated against six human Cancer cell lines. Among tested compounds, 6 and 9 showed potent cytotoxicity (IC50 values: 7.7-72 nM). Especially, 6 exhibited the strongest cytotoxicity with an IC50 value of 7.7 nM against the NUGC-3 (stomach) cell line, displaying 19-fold stronger activity than the positive control, adriamycin.

Figures